arrow
F

Fariba Navid

University of Southern California
H指数:41
被引数:5,617

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial

Tra贝替丁和低剂量伊立替康靶向EWS::FLI1在尤因肉瘤中的作用: 1/2期试验

2026-04-160
PRE
ESFT13: A Phase II Study Evaluating the Addition of Window and Maintenance Therapy to a Standard Chemotherapy Backbone for the Treatment of High-Risk Ewing Sarcoma

ESFT13:一项评估在标准化疗基础上增加窗口期治疗和维持治疗以治疗高危尤因肉瘤的II期研究

2025-09-040
OAAI
Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children’s Oncology Group

新型药物在儿童非横纹肌肉瘤软组织肉瘤中的优先级排序及进一步研究的报告:来自儿童肿瘤组的报告

2025-07-060
PRE
An Exome Capture-Based RNA-Sequencing Assay for Genome-Wide Identification and Prioritization of Clinically Important Fusions in Pediatric Tumors
2024-02-012
OAAI
The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients
2020-03-01285
OAAI
A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy

评估贝伐单抗加入标准骨肉瘤治疗可行性的II期临床试验

2017-07-0349
OAAI